| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |